Nexium

More Ways to Fight Hunger with Feeding America this Holiday Season

Retrieved on: 
Thursday, December 7, 2023
Nexium, Odyssey, Holiday, Meal, Home Chef, Instacart, Food Lion, Joy, Food, Bigelow Tea Company, Coca-Cola, Tea, The Coca-Cola Company, Shimek, Level, Social media, Starbucks, Blackhawk Network Holdings, Face, Hunger, Pep Simek, Food industry, Online shopping, Feeding America, Esomeprazole, Publix

"We are grateful for our partners' commitment to fighting hunger and for providing opportunities for everyone to give back this holiday season."

Key Points: 
  • "We are grateful for our partners' commitment to fighting hunger and for providing opportunities for everyone to give back this holiday season."
  • Here are the many ways shoppers can help fight hunger during this giving season:
    Blackhawk Network : Blackhawk Network Giving Good gift cards help support Feeding America's mission through each purchase.
  • Coca-Cola: The Coca-Cola Company is making a $100,000 donation and inviting Publix consumers to help local families experiencing hunger from the Holiday Content Hub, taking them to a Feeding America donation page.
  • People can help fight hunger this holiday season in other ways, such as volunteering, making a donation or engaging on social media.

PM360 Announces Winners of The Ninth Annual ELITE 100 Awards

Retrieved on: 
Tuesday, May 16, 2023
Nexium, Data science, Marketing, GoodRx, EVP, Hospira, Associate, Cardinal Health, Patient, McCourt, HR, Disease, Eli Lilly and Company, Constipation, Attention, Snow, Diagnosis, Entrepreneurship, Growth, Digital marketing, Immunology, FAAN, Engagement, Organon, Caregiver, PR, Ironwood Pharmaceuticals, Exception, COVID-19, IBS-C, Health, ELITE, Boehringer Ingelheim, Abdominal pain, Sustainability, ImmunoGen, RN, Bloating, CO, Providers, Glaucoma, Lead, Mirati Therapeutics, Regulatory science, AstraZeneca, HCP, Gastroesophageal reflux disease, Veeva Systems, Novartis, Omeprazole, Management, Pharmaceutical industry, Beauty salon, Generic drug, Esomeprazole, GERD

NEW YORK, May 16, 2023 /PRNewswire/ -- PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced the winners of its 9th Annual ELITE 100. The ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people and teams in the healthcare and life sciences industries based on their career accomplishments. Out of more than 500 submissions, 100 winners are selected by the PM360 editorial staff across various categories that span every facet of the industry.

Key Points: 
  • NEW YORK, May 16, 2023 /PRNewswire/ -- PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced the winners of its 9th Annual ELITE 100.
  • Out of more than 500 submissions, 100 winners are selected by the PM360 editorial staff across various categories that span every facet of the industry.
  • PM360 also selects one person as the "Uber ELITE," or the individual among the nominees who best personifies the criteria of a PM360 ELITE.
  • McCourt will serve as the keynote speaker at the annual ELITE 100 Awards Event to celebrate this year's winners.

Antitrust Violation vs. Injury-in-Fact: A distinction that makes a difference

Retrieved on: 
Saturday, February 4, 2023
Nexium, Laboratory, Supreme, Character, Ranbaxy Laboratories, AstraZeneca, Actavis, Government, Risk, Law of the United Kingdom, Policy, United States Court of Appeals for the First Circuit, Esomeprazole, Patent, Pharmacy, District of Columbia Court of Appeals v. Feldman, Supreme court, FTC, Ridesharing company

But private plaintiffs must make an additional showing: to establish antitrust ‘standing,’ private plaintiffs must prove that the antitrust violation caused harm to them.

Key Points: 
  • But private plaintiffs must make an additional showing: to establish antitrust ‘standing,’ private plaintiffs must prove that the antitrust violation caused harm to them.
  • This distinction is deeply rooted in our system of antitrust enforcement, which permits many types of enforcers but limits standing to those with a cognizable claim of injury.
  • But when courts and litigants miss this doctrinal distinction on the road to resolving a case, it can have significant implications for antitrust law and policy.
  • The brief takes no position on the merits of the case, but instead explains that the district court missed the important distinction between an antitrust violation and an injury-in-fact.

Haleon and Microsoft use AI to enhance health product accessibility for people who are blind or partially sighted

Retrieved on: 
Thursday, October 13, 2022
Nexium, App Store (iOS/iPadOS), CDC, List of toothpaste brands, Ibuprofen, Policy, Android, Diclofenac, NYSE, Multimedia, Severe cognitive impairment, Microsoft, Nasdaq, Artificial intelligence, Technology, Mental health, Partnership, HLN, Health, Fibre supplements, AI, Seeing AI, Dentistry, MSFT, ChapStick, Nicorette, Centrum, 1-Docosanol, Aspirin/paracetamol/caffeine, TUMS, Wellness, Engineering, Medical device, Pharmaceutical industry, Video game console, Esomeprazole, Parodontax, Cold medicine, Fluticasone propionate, Sensodyne

REDMOND, Wash., Oct. 12, 2022 /PRNewswire/ -- On Wednesday, Haleon, a global leader in consumer health, and Microsoft Corp. announced a new collaboration to make everyday health more accessible for people who are blind, have low vision or have difficulty reading product labels due to low literacy. Together, the companies are expanding functionality in the Microsoft Seeing AI app to provide consumers with more detailed labelling information for over 1,500 Haleon products across the U.S. and U.K. Seeing AI is a free mobile app designed to help people who have trouble seeing by narrating the world around them.              

Key Points: 
  • - New enhancements in the free Microsoft Seeing AI app will help advance inclusivity and improve accessibility.
  • Seeing AI is a free mobile app designed to help people who have trouble seeing by narrating the world around them.
  • With today's launch on World Sight Day, people will hear packaging information through Seeing AI by scanning the barcode of Haleon products.
  • Haleon initiated this collaboration with Microsoft via its Seeing AI app to make consumer health more accessible, achievable and inclusive.

Alnylam Announces New Management Appointments

Retrieved on: 
Wednesday, September 21, 2022
Biotechnology, Pharmaceutical, Genetics, Health, Nexium, Therapy, Gene silencing, RNA interference, Sirna, Twitter, RNA transfection, Alexion Pharmaceuticals, Nobel Prize, Rosuvastatin, LinkedIn, Compliance, Cognizant, Takeda Pharmaceutical Company, Nobel Prize in Physiology or Medicine, Merck Serono, Physiology, Patient, IPO, Oncology, Finance, Instagram, Biology, Valuation, Cell, AstraZeneca, Nasdaq, Medication, Novartis, General manager, Hess Corporation, Drug development, Science, RNA, Biotechnology, Corporate development, Bachelor of Medicine, Bachelor of Surgery, Pfizer, Interferon beta-1a, Pharmaceutical industry, Alnylam Pharmaceuticals, Esomeprazole, Takeda, Medicine

In each case, their expertise will be invaluable as we continue to execute on our Alnylam P5x25 strategy, said Yvonne Greenstreet, MBChB, Chief Executive Officer of Alnylam.

Key Points: 
  • In each case, their expertise will be invaluable as we continue to execute on our Alnylam P5x25 strategy, said Yvonne Greenstreet, MBChB, Chief Executive Officer of Alnylam.
  • He joins Alnylam from Alexion Pharmaceuticals where he served as the Head of Compliance.
  • Alnylam has a deep pipeline of investigational medicines, including multiple product candidates that are in late-stage development.
  • For more information about our people, science and pipeline, please visit www.alnylam.com and engage with us on Twitter at @Alnylam , on LinkedIn , or on Instagram .

Nicorette is Motivating Smokers to Take Healthier Breaks with a Customized Music Listening Experience, SmokeLess Break Beats

Retrieved on: 
Wednesday, July 27, 2022
Smoke, Nexium, Brain, Smoker, Occupational burnout, Nicotine, Wellness, Heart rate, Nicotine replacement therapy, Diclofenac, Student, Music therapy, Ideation, Tobacco, NYSE, Smoking, Berklee College of Music, Solution, Fatigue, Aspirin/paracetamol/caffeine, Health, Dentistry, NRT, Marketing, Relaxation, ChapStick, Centrum, TUMS, Science, Ibuprofen, Fibre supplements, Mindfulness, Program, 1-Docosanol, Nicorette, HLN, Music, Spotify, Esomeprazole, Cold medicine, Parodontax, Fluticasone propionate, Music, Sensodyne

WARREN, N.J., July 27, 2022 /PRNewswire/ -- Today, Nicorette unveils SmokeLess Break Beats – a first-of-its kind, customized music listening experience that uses the science of music therapy to address smokers' needs and motivate them towards healthier breaks. Nicorette has partnered with Berklee Music and Health Institute to enlist 30+ students and faculty to design eight original tracks, referencing scientific research about overcoming smoking addiction. These original compositions are featured in four playlists that promote relaxation, focus, confidence, and physical release, which are key benefits smokers seek in smoke breaks. Available for free on Spotify, each playlist contains the original tracks and is personalized using the listener's music history, functioning as a break-time emotional and behavioral tool to aid in smoking cessation.

Key Points: 
  • Developed in Partnership with Berklee Music and Health Institute, Program Will Feature Original Music and Encourage Smokers to Listen During Smoke-Less Breaks.
  • WARREN, N.J., July 27, 2022 /PRNewswire/ -- Today, Nicorette unveilsSmokeLess Break Beats a first-of-its kind, customized music listening experience that uses the science of music therapy to address smokers' needs and motivate them towards healthier breaks.
  • Smoke breaks are ingrained in smoking culture, serving as "treasured moments" that routinely help smokers slow down and relax.
  • SmokeLess Break Beats is designed to help smokers keep the habit of taking breaks but replace the cigarette with listening to music instead," explained Dan Wertheim, Brand Manager, U.S. Smokers' Health, Haleon.

ARS Pharmaceuticals Expands Executive Leadership Team with Addition of Pharmaceutical Commercialization Veterans

Retrieved on: 
Wednesday, February 9, 2022
Nexium, ARS, Biting, Cephalon, Allergy, Multimedia, VIAGRA, Woman, Food, Anaphylaxis, Research, Pfizer, Marketing, Leadership, SAN, Patient, Adrenaline, Caregiver, Biotechnology, Emergency, IQVIA, Record, Temple University, MBA, Pharmaceutical industry, Management, Esomeprazole

"The appointments of both Harris and Dan to the ARS team represent another building block in our ongoing commercialization preparations for neffy.

Key Points: 
  • "The appointments of both Harris and Dan to the ARS team represent another building block in our ongoing commercialization preparations for neffy.
  • Harris Kaplan, MBA, executive vice president, commercial strategy,will join the ARS commercial team as lead for commercial strategy and oversee launch preparations for neffy.
  • He has extensive experience in establishing and building new product planning initiatives, leadership and development programs and managing global strategic operations.
  • ARS Pharmaceuticals is dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis.

Hagens Berman: Sun and Ranbaxy Facing January Trial as Federal Judge Denies Summary Judgment in Generic Drug Overpricing Lawsuit

Retrieved on: 
Tuesday, November 23, 2021
Legal, Professional Services, Nexium, District, News, Paonta Sahib, Trailblazer, United States antitrust law, Complaint, Sherman Antitrust Act of 1890, RICO, Compliance, LTD, Sun Pharma, Ranbaxy Laboratories, MVP Baseball (series), Lists of action films, Food and Drug Administration, Fraud, Deception, FDA, Sun, District court, Hagens, Sherman, Douglas v. U.S. District Court ex rel Talk America, Food, Generic drug, Pharmaceutical industry

The federal racketeering statute (RICO) and the Sherman Act, which underpin the claims in the lawsuit, require automatic trebling of damages as a punitive measure against violators.

Key Points: 
  • The federal racketeering statute (RICO) and the Sherman Act, which underpin the claims in the lawsuit, require automatic trebling of damages as a punitive measure against violators.
  • In his 40-page order issued Nov. 22, 2021, United States District Judge Nathaniel M. Gorton rejected two of Suns key defenses.
  • But the court reject[ed] defendants assertions that the fact that Ranbaxy never sold Valcyte and Nexium... is dispositive of the Sherman Act claims.
  • Attorneys say Ranbaxy recklessly stuffed generic drug approval queues with grossly inadequate applications, deceiving the FDA into granting tentative approvals to lock in statutory exclusivities to which Ranbaxy was not entitled.

New Survey Reveals 70 Percent of Americans Forced to Give Up What They Love Due to Heartburn

Retrieved on: 
Thursday, November 18, 2021
Nexium, Patient, Research, ESOMAR, Burn, Esomeprazole, Relaxation, Anxiety, Movement, Mindfulness, Public opinion, Internal, Time, Brain, GlaxoSmithKline, Capsule, Opinion, Exercise, American Association for Public Opinion Research, Diet, Marketing, Yoga, Market Research Society, Dentistry, COVID-19, Heartburn, Sleep, Endorphins, AAPOR, OnePoll, Trust, Love, Internal medicine, Tablet, OTC, Social media, Friends, Uncertainty, Science, European Society of Neurogastroenterology and Motility, Swimming, American Association, Walking, Multimedia, Association, Prestige Consumer Healthcare, Life, Travel, Meditation, Animal, Medical device, Pharmaceutical industry, Online shopping

Surprisingly, the uncertainty surrounding COVID-19 isn't the only reason Americans are anxious about a return to normal activities.

Key Points: 
  • Surprisingly, the uncertainty surrounding COVID-19 isn't the only reason Americans are anxious about a return to normal activities.
  • The heightened stress is particularly impactful for the more than half of respondents (56%) who suffer from frequent heartburn, experiencing heartburn two or more days a week.
  • One dose provides all-day and all-night relief by blocking acid production directly at the source, so you can treat frequent heartburn.
  • This online, double opt-in survey of 2,000 general population Americans was conducted by OnePoll on behalf of Nexium24HR in August 2021.

Lowey Dannenberg, P.C. and The Dugan Law Firm, APLC Announce Court's Certification of Class Action Involving Third-Party Payors' Payment or Reimbursement for Some or All of the Purchase Price of Generic Nexium (esomeprazole magnesium), Brand or Generic Di

Retrieved on: 
Friday, November 5, 2021
Nexium, Valsartan, Person, South African Class ES, City, Pharmacy, AB, Plasma protein binding, Insurance, MDL Information Systems, TPP Nikola Tesla, Judgement, Ranbaxy Laboratories, John Joseph Moakley United States Courthouse, Maryland Office of the Public Defender, Court, MDL, District, FDA, TPP, Generic drug, Health insurance, Pharmaceutical industry, Maple syrup

Your rights may be affected by a class action lawsuit regarding the price paid for generic Nexium, brand and generic Diovan, and brand and generic Valcyte by Third-Party Payors ("TPPs") filed against Defendants Sun Pharmaceutical Industries, Ltd. And Ranbaxy, Inc.

Key Points: 
  • Your rights may be affected by a class action lawsuit regarding the price paid for generic Nexium, brand and generic Diovan, and brand and generic Valcyte by Third-Party Payors ("TPPs") filed against Defendants Sun Pharmaceutical Industries, Ltd. And Ranbaxy, Inc.
  • The case name is In Re Ranbaxy Generic Drug Application Antitrust Litigation, MDL No.
  • You are a member of the Class(es) if you are a TPP and you purchased or provided reimbursement for prescription drugs as described as follows:
    Generic Nexium Nationwide Class.
  • Any changes to the date or location of the trial will be posted to the case website.